Thomas J. Herzfeld Advisors, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 196 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
Thomas J. Herzfeld Advisors, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$45,000
-16.7%
5,0000.0%0.02%
-19.0%
Q2 2019$54,000
+12.5%
5,0000.0%0.02%
+16.7%
Q1 2019$48,000
-15.8%
5,0000.0%0.02%
-21.7%
Q4 2018$57,000
-32.9%
5,0000.0%0.02%
-23.3%
Q3 2018$85,0005,0000.03%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders